When HIRA estimate that the device has good treatment effect but is not cost-effective than other alternative products or treatment method, it can be classified as allowed payable device. In this case, doctor can used the device for the treatment of the designated disease on the burden of patient. It has similar effect of approval that doctor can sell the device to patient directly without any limit.